ACOS: Reducing Costs While Improving Quality of Care
With the push to reduce the cost of healthcare yet improve the quality and efficiency of care, Accountable Care Organizations could be a solution.
Reimbursement FAQs: IVIG vs SCIG, Medicare Benefits and More
We’re answering questions about switching from intravenous immune globulin therapy to subcutaneous immune globulin therapy, copayment for self-injectables, the definition of homebound patients and more.
The Effects of Healthcare Reform on the Healthcare Industry
What effects can insurance companies, physicians, hospitals and the biopharmaceutical industry expect from the gradual implementation of healthcare reform law?
Misdiagnosed: The Causes, Effects and (Possible) Remedies of a Medical Malady
While there has been virtually no decrease in the number of medical misdiagnoses in the U.S., awareness of the problem is growing, resulting in increased recommendations for reducing the incidence rate.
Reimbursement FAQs: Coding System Updates and Other News
Discussing reimbursement codes and insurance coverage of Fluzone and off-label uses for Rituxan.
Reimbursement FAQs: Vaccines
Understanding how to manage costs and reimbursement for vaccines.
Reimbursement FAQs: Documentation, Medicare Coverage, Factor Products and Qualifiers
Clarifying some commonly held misunderstandings about healthcare reimbursement.
Preventable Harm: Averting Medication Errors
To err may be human, but when it comes to medication mistakes, the consequences can be deadly. Remedying the problem will require coordinated interventions across all sectors of the healthcare system.
Stamp of Approval: H1N1 and the Flu Vaccine Licensing Process
The extensive process through which the FDA approved the 2009 H1N1 flu vaccine mirrors what is required for the licensure of seasonal flu vaccines
Bad Medicine: The War on Counterfeit Drugs
When it comes to preventing counterfeit drugs from tainting the supply chain, solutions are far from simple. Meaningful preventive measures will require education and legislation on federal and state levels, and within the industry itself.